Medicine
Procto-Med HC 2.5% cream
Procto-Med HC 2.5% cream is a prescription medicine containing Hydrocortisone for topical use, marketed by Leading Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20-25°C (68-77°F).
Key facts
- Active ingredient (INN)
- Hydrocortisone
- Brand
- Procto-Med HC
- Strength
- 2.5%
- Dosage form
- Cream
- Route
- Topical
- Packs
- 1 tube
- Marketing authorisation holder
- Leading Pharma
- Manufacturers
- Leading PharmaNuCare Pharmaceuticals,IncRedpharm Drug
- Origin register
- US FDA, United States
- Storage
- Store at 20-25°C (68-77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A01AC03 Hydrocortisone
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 February 2020
- Identifiers
- RxCUI 310891, 1790684DailyMed set ID 5f988ed9-7d5e-7976-e063-6294a90aa9f2, 4b972547-5bd4-155d-e063-6394a90a03ee, 0682580e-aff8-4b67-99ba-a29ab7b433dbNDC 67296-2366, 68071-3968, 69315-312Application ANDA085025
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 28 g in 1 tube | 69315-312-28 | Leading Pharma | 14 February 2020 |
| 1 tube in 1 carton / 28 g in 1 tube | 68071-3968-1 | NuCare Pharmaceuticals,Inc | 24 February 2026 |
| 1 tube in 1 carton / 28 g in 1 tube | 67296-2366-1 | Redpharm Drug | 14 February 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Hydrocortisone 2.5% cream.
- Hydrocortisone 2.5% creamAvailable on request—US FDA40 packs
- Proctozone-hc 2.5% creamAvailable on requestRising Pharma HoldingsUS FDA5 packs
- Alacort 2.5% creamAvailable on requestCrown LaboratoriesUS FDA3 packs
- Proctosol-HC 2.5% creamAvailable on requestSun Pharmaceutical IndustriesIndiaUS FDA2 packs
- Anusol HC 2.5% creamAvailable on requestSalix PharmaceuticalsUS FDA1 pack
Other strengths and forms of Hydrocortisone
Clinical summary
Hydrocortisone is a corticosteroid indicated in conditions. It is available as cream, tablets and ointment for topical, oral and intramuscular use. MedsAcross supplies Hydrocortisone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about HydrocortisoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Hydrocortisone prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Alkindi: European public assessment report (EPAR) · European Medicines Agency
- Efmody: European public assessment report (EPAR) · European Medicines Agency
Need Procto-Med HC 2.5% cream for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.